Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)
Showing 26 - 50 of >10,000
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)
Completed
- Human Immunodeficiency Virus
- Ad26.Mos4.HIV
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Feb 7, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +11 more
- Letermovir
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)
Completed
- Human Immunodeficiency Virus
- Ad26.Mos.HIV
- +2 more
-
Bangkok, Thailand(unnamed)
Dec 29, 2021
Ebola Virus Disease Trial in Entebbe (Ad26.ZEBOV/MVA-BN-Filo)
Completed
- Ebola Virus Disease
-
Entebbe, UgandaMRC/UVRI & LSHTM Uganda Research Unit
May 10, 2021
Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient Trial in Duarte (Laboratory Biomarker Analysis, Multi-peptide
Recruiting
- Cytomegaloviral Infection
- Hematopoietic Cell Transplant Recipient
- Laboratory Biomarker Analysis
- Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 14, 2022
HIV Trial in United States (GEO-D03 DNA vaccine, MVA/HIV62B (MVA62B) vaccine, Placebo for GEO-D03 DNA)
Completed
- HIV Infections
- GEO-D03 DNA vaccine
- +3 more
-
Birmingham, Alabama
- +3 more
Oct 13, 2021
High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin
Not yet recruiting
- High Grade B-Cell Non-Hodgkin's Lymphoma
- +3 more
- Anti-CD19-CAR CMV-specific T-lymphocytes
- +9 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 5, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +12 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +2 more
Feb 17, 2022
Malaria Trial (Pyronaridine Tetraphosphate, Artesunate Drug Combination, PfSPZ Challenge (NF54), MVA ME-TRAP)
Not yet recruiting
- Malaria
- Pyronaridine Tetraphosphate, Artesunate Drug Combination
- +4 more
- (no location specified)
Jun 27, 2022
Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic
Not yet recruiting
- Chronic Lymphocytic Leukemia
- COVID-19 Infection
- Biospecimen Collection
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 3, 2023
Safety Issues Trial run by the (MVA-BN-Brachyury/ FPV-Brachyury)
Completed
- Safety Issues
- MVA-BN-Brachyury/ FPV-Brachyury
-
Bethesda, MarylandGenitourinary Malignancies Branch National Cancer Institute
Aug 25, 2020
Solid Tumor, Adult Trial in United States (GAd-209-FSP low dose, MVA-209-FSP low dose, GAd-209-FSP high dose)
Recruiting
- Solid Tumor, Adult
- GAd-209-FSP low dose
- +5 more
-
Duarte, California
- +12 more
Oct 2, 2022
Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)
Recruiting
- Cytomegalovirus Infections
- +2 more
- CMV-MVA Triplex
- Placebo
-
Birmingham, Alabama
- +11 more
Jun 20, 2022
COVID-19 Infection Trial in Duarte (Placebo Administration, Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1)
Recruiting
- COVID-19 Infection
- Placebo Administration
- Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Dec 15, 2021
Monkey Pox, Monkey Diseases Trial in Paris (Vaccination with MVA vaccine ( IMVANEX® and JYNNEOS®))
Recruiting
- Monkey Pox
- Monkey Diseases
- Vaccination with MVA vaccine ( IMVANEX® and JYNNEOS®)
-
Paris, FranceCIC Cochin-Pasteur
Jul 13, 2022
B-Cell Non-Hodgkin Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Duarte (Anti-CD19-CAR CMV-specific T-lymphocytes, Autologous
Not yet recruiting
- B-Cell Non-Hodgkin Lymphoma
- +7 more
- Anti-CD19-CAR CMV-specific T-lymphocytes
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 28, 2022
Respiratory Syncytial Virus Infections Trial in United States (MVA-BN-RSV vaccine, Tris Buffered Saline (TBS))
Active, not recruiting
- Respiratory Syncytial Virus Infections
- MVA-BN-RSV vaccine
- Tris Buffered Saline (TBS)
-
Athens, Alabama
- +119 more
Jan 16, 2023
RSV Infection Trial in London (MVA-mBN294B, Placebo)
Completed
- RSV Infection
- MVA-mBN294B
- Placebo
-
London, United KingdomhVIVO Services Limited
Mar 31, 2022
COVID-19 Infection, Hematopoietic and Lymphoid System Tumor, Leukemia Trial in Duarte (COVID-19 Vaccine, Diagnostic Laboratory
Recruiting
- COVID-19 Infection
- +4 more
- COVID-19 Vaccine
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 2, 2021
Ebola Disease, Marburg Disease Trial in Atlanta (Ad26 Zaire Ebola Vaccine, MVA Multi-Filo Ebola Vaccine)
Completed
- Ebola Disease
- Marburg Disease
- Ad26 Zaire Ebola Vaccine
- MVA Multi-Filo Ebola Vaccine
-
Atlanta, GeorgiaEmory Children's Center - Pediatric Infectious Diseases
Feb 18, 2021
Monkeypox, Monkey Pox Trial in Amsterdam (Natural course of disease)
Recruiting
- Monkeypox
- Monkey Pox
- Natural course of disease
-
Amsterdam, Noord-Holland, NetherlandsPublic Health Service
Oct 4, 2022
COVID-19 Vaccines Trial in Hannover (MVA-SARS-2-ST)
Recruiting
- COVID-19 Vaccines
- MVA-SARS-2-ST
-
Hannover, GermanyHannover Medical School ZKS - Early Clinical Trial Unit at CRC H
Sep 6, 2022
Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)
Not yet recruiting
- Advanced Solid Tumors
- Recombinant human IL-21 oncolytic vaccinia virus injection
-
Hangzhou, Zhejiang, China
- +1 more
Jun 21, 2023